Lucintel Forecasts the Global Pain Therapeutic Injectable Market to Reach$26.9 billion by 2030
Lucintel Forecasts the Global Pain Therapeutic Injectable Market to Reach$26.9 billion by 2030
Blog Article
According to a market report by Lucintel, the future of the global pain therapeutic injectable market looks promising with opportunities in the hospital pharmacy, specialty clinic, long term care center, retail pharmacy, drug store, and online pharmacy markets. The global pain therapeutic injectable market is expected to reach an estimated $26.9 billion by 2030 from $20.4 billion in 2024,at a CAGR of 4.7% from 2024 to 2030. The major drivers for this market are rising incidence of chronic pain conditions include cancer discomfort, arthritis, and lower back pain, increasing number of surgeries carried out worldwide, and increasing acceptance of injectable medicines and the rising public awareness about pain management choices.
A more than 150-page report to understand trends, opportunity and forecast in pain therapeutic injectable market to 2030 by drug class (opioids, NSAID, local anesthetics, and acetaminophen), product (OTC products and prescription drugs), indication (surgical pain, cancer pain, neuropathic pain, musculoskeletal and joint pain, and others), end use (hospital pharmacies, specialty clinics, long term care centers, retail pharmacies, drug stores, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the drug class category, opioid will remain the largest segment over the forecast period due to they commonly used to manage pain, particularly when there is severe acute pain or persistent pain that does not improve with other kinds of treatment.
Within the end use category, retail pharmacy will remain the largest segment due to they have an extensive range of pharmaceuticals, including over-the-counter, prescription, and other healthcare items.
Download sample by clicking on pain therapeutic injectable market
In terms of regions, North America will remain the largest region over the forecast period.
AbbVie, Bristol Myers Squibb, Sanofi, BoehringerIngelheim International, copyright, ZydusLifesciences, GSK, Abbott Laboratories, Novartis, Johnson & Johnson are the major suppliers in the pain therapeutic injectable market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.comTo get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Green Hydrogen Market
Commercial Vehicle Air Dryer Market
Cosmetic Pigment Market
Functional Coating Market
Hand-Held Surgical Instrument Market